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This journal is ª The Royal Society ofAn iron silicate based pH-sensitive drug delivery system
utilizing coordination bonding†
Pengxin Liu, Mei Chen, Cheng Chen, Xiaoliang Fang, Xiaolan Chen
and Nanfeng Zheng*
Herein we report a drug delivery system based on hollow iron silicate nanospheres. Fe3+ on the
nanospheres’ surface can effectively bind with doxorubicin (DOX), an anticancer drug, through
coordination bonds. The bonds are fairly stable in a neutral environment but could easily break up in an
acid environment. The release of DOX from hollow iron silicate nanospheres into cancer cells can be
therefore triggered by a pH drop caused by endocytosis. The iron silicate shell allows a DOX loading
content of up to 50.2% in weight, which is significantly higher than most drug delivery systems
reported. Cell experiments show that DOX-loaded hollow iron silicate nanospheres exhibit a higher
efficiency in killing cancer cells than free DOX, and a higher cytotoxicity for human hepatoma cells than
hepatocyte cells at the same DOX-loaded nanospheres’ concentration. Confocal laser scanning
microscopy (CLSM) experiments show the releasing and transportation process of DOX, and confirm the
enrichment of DOX in cell nuclei.1 Introduction
Cancer therapeutic agents are mostly toxic to both cancer and
healthy cells, which causes side effects and permanent
damage.1 In order to minimize the side effects, nanoparticle-
based drug delivery systems able to achieve “zero-premature
release”, i.e. controlled release systems, have attracted much
attention.2–4 Ideal controlled release systems should rst
possess good biocompatibility and long blood circulation time;5
hence they accumulate in tumor tissues owing to the enhanced
permeability and retention (EPR) effect. Moreover, under the
effect of endo- or ecto-stimuli, like pH change, electrochemical,
photochemical or ionic stimuli, loaded cargos could be
released.4 In this way, the pharmacokinetics and bio-
distributions of loaded drugs can be well controlled.5 Targeting
agents have also been helpful to full these demands.6,7
Among all the materials developed, mesoporous silica
nanoparticle (MSN) based delivery systems with good biocom-
patibility, high surface areas and easily modied surfaces have
been demonstrated to be good candidates for various
biochemical applications,8–11 such as imaging,12,13 genery of Solid Surfaces and Department of
emical Engineering, Xiamen University,
mu.edu.cn
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Chemistry 2013therapy,14,15 photothermal therapy16–18 and especially in
controlled release systems.19–21 In order to design MSN-based
controlled release systems, many strategies have been demon-
strated, like using removable or soluble nanoparticles as
blocking caps,4,22–25 supramolecular nanovalves,26,27 poly-
electrolyte multilayers28,29 or a pH-sensitive cross-linked poly-
meric network on the surface of the mesoporous silica30–32 to
prevent the cargos from leaching.
However, multistep modifying and fabricating processes are
generally required to prepare the materials mentioned above.
Solvents and ligands applied in modifying processes are not
totally nontoxic to cells. At the same time, although the “zero-
premature release” property is very important, low loading
capacity and fast releasing characteristics are still the main
shortcomings of MSN-based drug delivery systems, which make
them not suitable for in vivo or clinical studies. Therefore, new
materials and releasing models are highly desired to overcome
these difficulties.
Herein, we present a pH-sensitive controlled release system
based on hollow iron silicate spheres (HISS). The porous shells
of HISS provide spaces for host–guest molecules, and more
importantly, provide Fe3+ ions on the surface to coordinate with
doxorubicin (DOX). To compare with preexisting silica-based
drug delivery systems, HISS do not need additional ligands and
modication processes to anchor drug molecules on their
surfaces. The coordination bonding between DOX and HISS is a
much stronger affinity than van der Waals forces, hydrogen
bonding and electrostatic attraction that are commonly used in
the adsorption of drug molecules. It can be observed that HISS-
loaded DOX hardly releases in Phosphate Buffered Saline (PBS,J. Mater. Chem. B, 2013, 1, 2837–2842 | 2837











































View Article OnlinepH¼ 7.4), but releases over 84% of the adsorbed DOX in an acid
environment (PBS, pH ¼ 5.0), meeting the “zero-premature
release” requirement. Another notable property of HISS is a
considerably larger loading content than MSN-based materials
reported, which is important in real clinical applications. As far
as we know, HISS are also the rst metal silicate material used
for a drug delivery system.2 Experimental
2.1 Materials
Iron(III) acetylacetonate Fe(acac)3, tetraethoxysilane (TEOS), and
urea were purchased from Alfa Aesar. Ethanol and concentrated
ammonia solution (28–30% NH3 in water) were obtained from
Sinopharm Chemical Reagent Co. Ltd. (Shanghai, China).
Doxorubicin hydrochloride was purchased from HuaFeng
United Technology Co. Ltd. (Beijing, China). Hela cells, human
hepatoma cells (QGY-7703) and human hepatocytes (QSG-7701)
were purchased from the cell storeroom of Chinese Academy of
Sciences. All reagents were used as received without further
purication.2.2 Synthesis
2.2.1 Synthesis of silica template. SiO2 templates were
prepared in a modied Stöber method. To make 75 nm SiO2,
3.15 mL concentrated ammonia, and 1 mL water were added to
60 mL ethanol. Aer stirring for 30 min, 2.3 mL tetraethoxy-
silane was added. The reaction mixture was further stirred for
6 h. The resultant colloids were centrifuged, fully washed by
ethanol and water, then redispersed in water.
2.2.2 Synthesis of hollow iron silicate nanospheres. 2.5 mL
of the above solution containing 25 mg SiO2 was mixed with
7.5 mL water containing 1.35 g urea. Then 88 mg Fe(acac)3 in
5 mL ethanol was added to the mixture, followed by ultrasonic
treatment. The suspension was transferred into a Teon-lined
stainless steel autoclave with a capacity of 25 mL, kept at 200 C
for 48 h, and then cooled to ambient temperature. The products
were collected by centrifugation, washed with deionized water
and absolute ethanol, and re-dispersed in deionized water.2.3 DOX loading and release
1.0 mg hollow iron silicate nanospheres were mixed with 2 mg
Doxorubicin hydrochloride in 1.0 mL PBS (pH ¼ 7.4), and stir-
red at room temperature for 36 h. The mixture was centrifuged
and washed eight times with PBS (pH ¼ 7.4). To measure the
amount of DOX loaded on HISS, the supernatant solutions
containing DOX molecules were measured for the uorescence
spectrum of DOX (ex ¼ 500 nm). The loading capacity of the
nanoparticles was determined as the percentage of the weight of
DOX related to the weight of HISS. To study the amount of drug
releasing from the mesoporous nanoparticles at different pH
values, 1 mg DOX loaded nanoparticles was dispersed in 1 mL
PBS buffer at pH values of 7.4, 6.7, 6.0 and 5.0, and shaken at
room temperature. The release media solution was collected by
centrifugation at a given time for analysis. The amount of DOX
molecules in the media solution was then measured by its2838 | J. Mater. Chem. B, 2013, 1, 2837–2842uorescence spectrum, to calculate the releasing percentage of
loaded DOX molecules.2.4 Characterizations
Transmission electron microscopy (TEM) studies were per-
formed on a TECNAI F-30 high resolution transmission electron
microscope operating at 300 kV. Scanning electron microscopy
(SEM) images were obtained on a Hitachi S4800 scanning
electron microscope with a eld emission electron gun. Surface
area and pore size were determined by a Surface Area and
Porosity Analyzer (Micromeritics Instrument Corp. ASAP2020).2.5 Cell culture
Hela cells, human hepatoma cells (QGY-7703) and human
hepatocytes (QSG-7701) were maintained in Duibecco's modi-
ed Eagle's medium (DMEM) supplemented with 10% calf
serum, 1% penicillin, 1% streptomycin in 37 C, 5% CO2.2.6 In vitro cytotoxicity assay
To study the cytotoxicity of the hollow iron silicate nanospheres,
QGY-7703 cells were seeded in a 96-well plate at a density of 104
cells per well for 24 h at 37 C in 5% CO2. Then the cells were
treated with free DOX, HISS/DOX or HISS nanoparticles at
desired concentrations. Aer incubation for 24 h, cell viabilities
were tested by standard MTT ((3-(4,5)-dimethylthiahiazo-2-yl)-
2,5-diphenyltetrazolium bromide) assay.2.7 Confocal uorescence imaging
1  104 human hepatoma cells (QGY-7703) per well were
cultured in an 8-well chamber slide and incubated with DOX-
loaded HISS. Aer 4 h and 12 h, the cells were washed with
phosphate buffered saline (PBS), xed with 4% para-
formaldehyde and stained with 40,6-diamidino-2-phenylindole
(DAPI, 1 mg mL1 in PBS). The uorescence images were
acquired by confocal laser scanning microscopy (CLSM) (Leica
TCS SP5).3 Results and discussion
HISS were prepared in a facile hydrothermal reaction through a
sacricial-templating process.33 We used a modied Stöber
method to synthesize a SiO2 template with an average diameter
of 75 nm, and then carried out the hydrothermal reaction. As
shown in Fig. 1, the obtained HISS particles had an average
diameter of 105 nm and a shell thickness of 10 nm. The robust
and rough surface was formed by small particles, which
increased the total surface area and interfacial Fe3+ amount.
Under hydrothermal conditions, urea would decompose into
ammonium salts gradually and result in an alkali environment.
In the alkaline conditions, SiO2 templates are slowly dissolved
into silicate anions which react with Fe(acac)3 to produce iron
silicate (see Scheme S1†). The dissolution/diffusion process
would eventually lead to the formation of hollow iron silicate
spheres. During the whole process, it is important to prevent the
formation of iron hydroxide. The balance between the pH valueThis journal is ª The Royal Society of Chemistry 2013
Fig. 1 Representative (a) SEM image of silica templates and (b) HISS. (c) TEM
images of HISS, (d) hydrodynamic diameter distribution of HISS in aqueous
dispersion, (e) energy dispersive X-ray spectroscopy of HISS. Fig. 2 (a) Fluorescence spectra showing the change of emission intensity of the
DOX solutions before treatment with HISS (black), supernatant after treatment
with HISS (red) and emission intensity of the collected supernatant after washing
treatment. (b) Continuous release kinetics of DOX from HISS in PBS buffer at two
different pH values. (c) FT-IR spectra of HISS, DOX and DOX loaded HISS after
washing treatment.











































View Article Onlineof the solution and the concentrations of Fe3+ and silicate
anions is thus essential. With a high concentration of OH, the
SiO2 spheres will be dissolved quickly at high temperature and
cannot act as templates. In the synthesis of HISS, the decom-
position of urea under hydrothermal conditions provides a
stable alkaline solution with a pH value of about 9.5 measured
at room temperature, which gives a slow dissolution rate of the
SiO2 spheres. Moreover, the use of iron(III) acetylacetonate as
the iron source is equally important to the successful synthesis
of HISS because of its property of being stable enough to avoid
fast hydrolysis but active to react with SiO2, leading to a
homogeneous incorporation of iron into the silica framework.
Considering the potential biochemical applications,
dynamic light scattering (DLS) experiments were carried out,
showing a narrow hydrodynamic diameter distribution around
118 nm in an aqueous dispersion, which is stable for weeks. As
shown in Fig. 1e, energy dispersive X-ray spectroscopy of HISS
indicated the successful incorporation of iron into the material.
XRD and XPS experiments were also carried out to conrm the
chemical composition of HISS.
The DOX loading ability of HISS was then studied. The
loading content was evaluated by monitoring the uorescence
of the DOX solutions before and aer treatment with HISS.
Based on the change of uorescence intensity of the superna-
tant aer treatment with HISS (Fig. 2a), over 1 milligram DOX
was adsorbed by 1 milligram HISS. The loading content of DOX
on HISS was calculated as high as 104.21 wt% related to the
weight of HISS (loading content¼mass of drugs loaded/mass of
HISS).
Then we studied the release kinetics of DOX from HISS in
PBS buffer. As shown in Fig. 2b, it was interesting to nd thatThis journal is ª The Royal Society of Chemistry 2013only about 46% of the total loaded DOX could be released in a
neutral environment. As the pH was lowered to 5.0, the rest of
the loaded DOX began to release. To determine the reason for
such a high DOX loading and uncommon release kinetics, we
washed the DOX-loaded HISS with PBS several times until the
supernatant showed no color. The supernatant was collected to
detect the amount of DOX released in the washing treatment by
uorescence spectroscopy. Aer the washing treatment, about
half of the loaded DOX was washed out. However, the loading
content of DOX on HISS was still as high as 50.2 wt% (calculated
by drug : HISS mass ratio), which has not been reported for
MSN or other silica-based materials. Only some previous work
using coordination bonding as loading strategy could have a
comparably large loading content.34 A large loading content is
an essential feature of a controlled release system for being an
in vivo investigation candidate.
To study the loading mechanism of DOX, we chose DOX
loaded HISS aer washing treatment (noted as DOX–HISS) as
the object of study. As shown in Fig. 2c, aer washing treatment,
DOX–HISS had a similar infrared absorption spectrum to DOX,
indicating the immobilization of DOX on HISS without
changing their structure. Free DOX and DOX–HISS showed
characteristic IR modes at 1727 cm1 due to the stretching
vibration of the C]O group at the 13-keto position, 1619 and
1583 cm1 from the stretching vibrations of the two C]O
groups of the anthracene ring (5-keto and 12-keto positions),
1412 cm1 due to C–H bending, a band at 992 cm1 due to theJ. Mater. Chem. B, 2013, 1, 2837–2842 | 2839
Fig. 4 Relative cell viability data of QSG-7703 cells (a) and Hela cells (b) incu-
bated with HISS at different concentrations.











































View Article Onlinestretching vibration of the C–O bonds, and a band higher than
3000 cm1 corresponding to the vibration of the –OH groups
with a contribution of –NH2 within this band. In the IR spec-
trum of DOX–HISS, a peak at 585 cm1 due to the characteristic
vibration of Fe–N was observed, indicating the loading mecha-
nism should be through coordination bonding, considering the
presence of iron atoms on the outer surface of HISS.
Aer the washing treatment in neutral environment, adsor-
bed and electrostatically attracted DOX on HISS was released,
but the loading content of DOX on HISS was still very high. In
general, coordination bonding is stronger than van der Waals
forces, hydrogen bonding or electrostatic attraction that are
commonly used in the adsorption of drugmolecules. We believe
the coordination bonds formed between HISS and DOX mole-
cules are the reason for such a high loading content. Utilizing
coordination bonding to load cargoes on/in drug delivery
systems has been recently demonstrated to be a smart idea.20,21
Aer removing the electrostatically attracted DOX by washing
treatment, all DOXmolecules loaded are bound to HISS through
–NH2–Fe
3+ coordination bonds which are fairly stable under a
neutral condition. Therefore DOX coordinated on HISS can
hardly be released unless attacked by acids. Through the
formation and cleavage of coordination bonding, a pH-sensitive
release property of drug delivery systems could be achieved,
which inspired us to study the release kinetics of HISS loaded
DOX at different pH values.
As clearly shown in Fig. 3a, HISS loaded DOX can barely be
released in PBS (pH ¼ 7.4), only 5% was leaked aer two days,
while in acid environment (PBS, pH ¼ 5.0), the continuous
releasing of DOX can reach up to 78.7% of the entire loaded
drug in the rst 10 hours. The success in controlling the DOX
release by pH conrms that using coordination bonding is an
effective strategy to achieve pH-sensitive releasing. As a matter
of fact, all cargoes with an amino-group or other functional
groups that can form strong coordination bonds with metal
ions could be adopted in this pH-sensitive release system.
In an acid environment, protons would compete with metal
ions to bind with loaded drug molecules, which could be
released due to the cleavage of coordination bonding. This
novel versatile pH-responsive strategy has been proved to beFig. 3 (a) Release kinetics of DOX from HISS in PBS buffer at different pH values.
(b) Zeta potential of naked HISS before DOX loading, and DOX loaded HISS after
washing treatments at different pH values.
2840 | J. Mater. Chem. B, 2013, 1, 2837–2842successful in a MSN based20 and a combined therapeutic
Pd@Ag@mSiO2 system.34 The advantage of HISS lies in the
presence of surface Fe3+ coordination sites without the need for
tedious surface modication work. Moreover, metal binding
sites introduced by surface ligands may leak during drug
delivery applications. The inherent iron-rich surface of HISS
indeed helped to show a similar, or even better “zero-premature
release” performance than other materials.
To conrm that DOX is bound onto HISS through strong
coordination bonds, we investigated the zeta potential of naked
HISS before DOX loading, and DOX loaded HISS aer washing
treatment at different pH values. As shown in Fig. 3b, the DOX-
loaded HISS showed a more positive zeta potential compared to
bare HISS. Take the values for pH ¼ 7.4 for example, HISS
showed a 42 mV zeta potential, while DOX loaded HISS
showed a 23 mV zeta potential. According to the double layer
theory, metal oxide particle surfaces in aqueous suspension are
generally covered with surface hydroxyl species, M–OH (where
M stands for a metal such as Al, Si, etc.). At pH values above the
isoelectric points (IEP), the predominate surface species is
M–O, while at pH values below the IEP, M–OH2
+ species
predominate. The electrokinetic behavior of the surface of HISS
was dominated by surface Si–O species, which is similar to a
reported aluminosilicate material and explains the relatively
low isoelectric point value. But aer DOX loading, the zeta
potentials of DOX loaded HISS are about 20 mV higher thanFig. 5 Relative cell viability data of QGY-7701 cells (a) and QSG-7703 cells (b)
incubated with free DOX and HISS–DOX at different concentrations.
This journal is ª The Royal Society of Chemistry 2013
Fig. 6 Confocal laser scanning microscopic images of QSG-7703 cells incubated
with DOX-loaded HISS for 4 h and 12 h. All the scale bars are 7.65 mm.











































View Article Onlinebare HISS, indicating the existence of positive species on the
surface.
On the other hand, the photoluminescence of loaded DOX
molecules was not quenched, indicating the loading process
was not through p–p stacking.35,36 The affinity was strong
enough to resist attacks from water molecules and ions in PBS,
which proved the mechanism of binding could only be the
formation of coordination bonds. In addition to the large
loading content attributed to the formation of coordination
bonds, another important feature related is the “zero-premature
release” property of HISS. When taken up by living cells through
endocytosis, particles would experience a pH drop to 5.5 or
even lower,37 which has motivated us to study the drug releasing
process in living cells.
Firstly we examined the biocompatibility of HISS. We incu-
bated human hepatoma cells and Hela cells with the nano-
particles at different concentrations for 24 h. The relative cell
viabilities were then revealed by MTT assay. No signicant
cytotoxicity was observed. The viability of the cells was only
reduced by 10% aer exposure to a HISS dispersion contain-
ing 200 ppm particles (Fig. 4), indicating that HISS particles
were highly biocompatible.16,34
To check if using the coordination bonding strategy had a
positive effect on cancer cell killing behavior, the release of
loaded DOX was studied in both human hepatoma cells (QGY-
7703) and hepatocyte (QSG-7701) cells. The cells were incubated
with free DOX and DOX-loaded HISS at different concentrations
for 12 h. The MTT assay was then carried out to test cell
viabilities. The DOX-loaded HISS exhibited a higher cytotoxicity
than free DOX at the same concentrations. This result can be
explained by the fact that DOX-loaded HISS can enter cancer
cells more easily than free DOX through an endocytosisThis journal is ª The Royal Society of Chemistry 2013mechanism. As shown in Fig. 5, when the dosing DOX
concentration was higher than 4 ppm, DOX loaded HISS
exhibited a higher cytotoxicity for hepatoma cells than free DOX
did. While at 5 ppm free DOX killed only 48% cells, the same
amount of DOX loaded on HISS particles killed 80% cells. Even
more signicant differences could be observed when we
increased the DOX dose.
Moreover, a higher cytotoxicity of DOX-loaded HISS in
hepatoma cells than in hepatocyte cells was also observed. This
phenomenon is consistent with our hypotheses, considering
cancer cells are mostly anaerobic and thus maintain more acidic
pH levels than normal cells.35 With increased DOX dosing, the
enhanced cytotoxicity became more notable for hepatoma cells.
However, in normal hepatocyte cells the situation is dramatically
different. At all dosing concentrations, DOX loaded on HISS
showed no obvious higher cytotoxicity than free DOX molecules.
By comparing the cytotoxicity of DOX-loaded HISS in hepatoma
cells and in hepatocyte cells, it could be concluded that aer
being taken up by living cells through endocytosis, DOX loaded
HISS would experience different pH drops, leading to a higher
cytotoxicity in hepatoma cells given a lower pH.
To conrm the actual release of DOX from HISS, confocal
laser scanning microscopy (CLSM) was conducted. Hepatoma
cells (QGY-7703) were incubated with DOX-loaded HISS for 4
hours and 12 hours, then the nuclei were labeled by 40,6-dia-
midino-2-phenylindole (DAPI, 1 mg mL1 in PBS). The uores-
cence images denitively demonstrated that HISS entered into
the cells. Furthermore, the merging of blue and red uores-
cence images reveals the location of HISS and the liberation of
doxorubicin molecules, as shown in Fig. 6. The red uorescence
aer 4 hours incubation was weaker compared to 12 hours.
Although red uorescence from DOX inside the cells was
observed aer 4 hours, a certain period of time is required for
the released DOX to reach the cell nuclei (blue) where DOX
actually acts on cells. Only aer 12 hour incubation, the pres-
ence of released DOX inside the DAPI stained nuclei was clearly
observed. This conrmed that DOX is released as a consequence
of the breaking of coordination bonds by low pH in endosomes,
and that the transportation of drugs from endosomes to cell
nuclei aer endocytosis takes some time.
It should be noted that the uorescence of DOX did not
spread all over the hepatoma cells’ cytoplasm. This is a direct
evidence for intracellular release of DOX, instead of premature
release before DOX–HISS entered hepatoma cells. The result
also showed that aer DOX loaded HISS entered cells, the
enrichment of DOX in cells could be achieved, which is the
reason why DOX loaded HISS showed a signicantly higher
cytotoxicity for hepatoma cells than normal cells.4 Conclusions
In summary, a well-designed anticancer drug delivery system
based on hollow iron silicate nanospheres has been developed.
The hollow architecture and rough surface result in a high-
surface area, with the high interfacial Fe3+ presence for the
loading of anticancer drug molecules (DOX). Through coordi-
nation bonds responsive to pH, the release of DOX from theJ. Mater. Chem. B, 2013, 1, 2837–2842 | 2841











































View Article Onlinehollow nanospheres can be triggered by pH, resulting in a
controlled release for cancer cell killing. The notable “zero-
premature release” property makes it a potential candidate for
in vivo experimental investigations.Acknowledgements
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